切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2025, Vol. 13 ›› Issue (03) : 178 -182. doi: 10.3877/cma.j.issn.2095-5820.2025.03.008

综述

急性缺血性脑卒中血压管理研究进展
张莉, 王汉祥()   
  1. 048000 山西 晋城,晋城市朝阳医院内科
  • 收稿日期:2024-05-21 出版日期:2025-08-28
  • 通信作者: 王汉祥

The research progress of blood pressure management in acute ischemic stroke

Li Zhang, Hanxiang Wang()   

  1. Department of Internal Medicine, Chaoyang Hospital, Jincheng Shanxi 048000, China
  • Received:2024-05-21 Published:2025-08-28
  • Corresponding author: Hanxiang Wang
引用本文:

张莉, 王汉祥. 急性缺血性脑卒中血压管理研究进展[J/OL]. 中华临床实验室管理电子杂志, 2025, 13(03): 178-182.

Li Zhang, Hanxiang Wang. The research progress of blood pressure management in acute ischemic stroke[J/OL]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2025, 13(03): 178-182.

急性缺血性脑卒中(AIS)也叫脑梗死,是一种急性脑血管疾病,全球每年新发人数超过700万,是目前世界上第二大死亡原因。我国现有患病人数超过2400万。在众多危险因素中,高血压是AIS最重要的独立相关因素,与其发病率及死亡率密切相关。AIS后血流动力学改变影响疾病的预后,因此急性期脑卒中的血压管理应贯穿全过程。但针对AIS患者,不同治疗方式的血压管理仍然是一个重要的悬而未决的问题,文中就近年来AIS的血压管理研究进展做一综述。

Acute ischemic stroke (AIS), also known as cerebral infarction, is an acute cerebrovascular disease with more than 7 million new cases worldwide every year, which is the second leading cause of death in the world. There are more than 24 million patients in China. Among the many risk factors, hypertension is the most important independent related factor of AIS, which is closely related to its morbidity and mortality. The hemodynamic changes after AIS affect the prognosis of the disease, so the management of blood pressure in the acute phase should be throughout the whole process. However, for patients with AIS, the management of blood pressure with different treatment methods is still an important outstanding issue. This paper reviews the research progress of blood pressure management in AIS in recent years.

1
WALTER K. What is acute ischemic stroke?[J]. JAMA, 2022, 327(9): 885.
2
SAINI V, GUADA L, YAVAGAL D R. Global epidemiology of stroke and access to acute ischemic stroke interventions[J]. Neurology, 97(20 Suppl 2): S6-S16.
3
AJOOLABADY A, WANG S, KROEMER G, et al. Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics[J]. Pharmacology & Therapeutics, 2021, 225: 107848.
4
HERPICH F, RINCON F. Management of acute ischemic stroke[J]. Critical care medicine, 2020, 48(11): 1654-1663.
5
CLAASSEN J A H R, THIJSSEN D H J, PANERAI R B, et al. Regulation of cerebral blood flow in humans: Physiology and clinical implications of autoregulation[J]. Physiological Reviews, 2021, 101(4): 1487-1559.
6
DEWITT D S, PROUGH D S. Cerebral blood flow and blood pressure: Dependent or codependent?[J]. Critical care medicine, 2019, 47(7): 1007-1009.
7
WEBB A J S, WERRING D J. New insights into cerebrovascular pathophysiology and hypertension[J]. Stroke, 2022, 53(4): 1054-1064.
8
DE HAVENON A, BENNETT A, STODDARD G J, et al.Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke[J]. Stroke and vascular neurology, 2017, 2(1): 1-6.
9
BATH P M, SONG L, SILVA G S, et al. Blood pressure management for ischemic stroke in the first 24 hours[J]. Stroke, 2022, 53(4): 1074-1084.
10
PETERSEN N H, SILVERMAN A, WANG A, et al. Association of personalized blood pressure targets with hemorrhagic transformation and functional outcome after endovascular stroke therapy[J]. JAMA neurology, 2019, 76(10): 1256-1258.
11
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE RT-PA STROKE STUDY GROUP. Tissue plasminogen activator for acute ischemic stroke[J]. The New England journal of medicine, 1995, 333(24): 1581-1587.
12
HERPICH F, RINCON F. Management of acute ischemic stroke[J]. Critical care medicine, 2020, 48(11): 1654-1663.
13
MOROTTI A, POLI L, COSTA P. Acute Stroke[J]. Seminars in neurology, 2019, 39(1): 61-72.
14
APPIAH K O, MINHAS J S, ROBINSON T G. Managing high blood pressure during acute ischemic stroke and intracerebral hemorrhage[J]. Current opinion in neurology, 2018, 31(1): 8-13.
15
MENDELSON S J, PRABHAKARAN S. Diagnosis and management of transient ischemic attack and acute ischemic stroke: A review[J]. JAMA, 2021, 325(11): 1088-1098.
16
WANG Y, YUAN X, KANG Y, et al. Clinical predictors of prognosis in stroke patients after endovascular therapy[J]. Scientific reports, 2024, 14(1): 667.
17
HILLIS A E, ULATOWSKI J A, BARKER P B, et al. A pilot randomized trial of induced blood pressure elevation: Effects on function and focal perfusion in acute and subacute stroke[J]. Cerebrovascular diseases, 2003, 16(3): 236-246.
18
LEONARDI-BEE J, BATH P M, PHILLIPS S J, et al. Blood pressure and clinical outcomes in the international stroke trial[J]. Stroke, 2002, 33(5): 1315-1320.
19
GEEGANAGE C, TRACY M, ENGLAND T, et al. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: Data from the Tinzaparin in acute ischaemic stroke trial (TAIST)[J]. Stroke, 2011, 42(2): 491-493.
20
NG F C, CHURILOV L, YASSI N, et al. Microvascular dysfunction in blood-brain barrier disruption and hypoperfusion within the infarct posttreatment are associated with cerebral edema[J]. Stroke, 2022, 53(5): 1597-1605.
21
MALHOTRA K, AHMED N, FILIPPATOU A, et al. Association of elevated blood pressure levels with outcomes in acute ischemic stroke patients treated with intravenous thrombolysis: A systematic review and meta-analysis[J]. Journal of stroke, 2019, 21(1): 78-90.
22
ANDERSON C S, HUANG Y, LINDLEY R I, et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): An international, randomised, open-label, blinded-endpoint, phase 3 trial[J]. Lancet, 2019, 393(10174): 877-888.
23
MISTRY E A, DAKAY K, PETERSEN N H, et al. Pre-endovascular therapy change in blood pressure is associated with outcomes in patients with stroke[J]. Journal of neurology neurosurgery and psychiatry, 2020, 91(4): 438-439.
24
ANADANI M, ARTHUR A S, ALAWIEH A, et al. Blood pressure reduction and outcome after endovascular therapy with successful reperfusion: A multicenter study[J]. Journal of neurointerventional surgery, 2020, 12(10): 932-936.
25
ANADANI M, ORABI M Y, ALAWIEH A, et al. Blood pressure and outcome after mechanical thrombectomy with successful revascularization[J]. Stroke, 2019, 50(9): 2448-2454.
26
MAÏER B, DELVOYE F, LABREUCHE J, et al. Impact of blood pressure after successful endovascular therapy for anterior acute ischemic stroke: A systematic review[J]. Frontiers in neurology, 2020, 11: 573382.
27
MATUSEVICIUS M, COORAY C, BOTTAI M, et al. Blood pressure after endovascular thrombectomy: Modeling for outcomes based on recanalization status[J]. Stroke, 2020, 51(2): 519-525.
28
MAZIGHI M, RICHARD S, LAPERGUE B, et al. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): A multicentre, open-label, randomised controlled trial[J]. The Lancet. Neurology, 2021, 20(4): 265-274.
29
YANG P, SONG L, ZHANG Y, et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): A multicentre, open-label, blinded-endpoint, randomised controlled trial[J]. Lancet, 2022, 400(10363): 1585-1596.
30
MISTRY E A, HART K W, DAVIS L T, et al. Blood pressure management after endovascular therapy for acute ischemic stroke: The BEST-Ⅱ randomized clinical trial[J]. JAMA, 2023, 330(9): 821-831.
31
NAM H S, KIM Y D, HEO J, et al. Intensive vs conventional blood pressure lowering after endovascular thrombectomy in acute ischemic stroke: The OPTIMAL-BP randomized clinical trial[J]. JAMA, 2023, 330(9): 832-842.
32
FISCHER U, MATTLE H P. Blood pressure in acute stroke: Still no answer for management[J]. Stroke, 2017, 48(7): 1717-1719.
33
CARLBERG B, ASPLUND K, HÄGG E. Factors influencing admission blood pressure levels in patients with acute stroke[J]. Stroke, 1991, 22(4): 527-530.
34
MAÏER B, GORY B, LAPERGUE B, et al. Effect of blood pressure variability in the randomized controlled BP TARGET trial[J]. European journal of neurology, 2022, 29(3): 771-781.
35
MAÏER B, TURC G, TAYLOR G, et al. Prognostic significance of pulse pressure variability during mechanical thrombectomy in acute ischemic stroke patients[J]. Journal of the American heart association, 2018, 7(18): e009378.
36
SAMUELS N, VAN DE GRAAF R A, VAN DEN BERG C A L, et al. Blood pressure during endovascular treatment under conscious sedation or local anesthesia[J]. Neurology, 2021, 96(2): e171-e181.
[1] 罗兵, 董凤群, 牛艺臻, 王锟, 程志华, 刘宏强. 胎儿超声心动图在单纯性肺动脉瓣狭窄及预后评估中的价值[J/OL]. 中华医学超声杂志(电子版), 2025, 22(08): 740-747.
[2] 贺雅莉, 黄丽, 杨培娟. 功能保留手术在低位直肠癌治疗中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 701-704.
[3] 杨志, 夏雪峰, 管文贤. DeepSurv深度学习模型辅助胃癌术后精准化疗策略研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 501-505.
[4] 徐其银, 韩尚志. 术前结合术后营养支持对直肠癌患者康复的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 543-546.
[5] 张聪, 李成. 胰头区恶性肿瘤外科手术预后现状及相关因素的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 574-578.
[6] 曾舒昊, 康博禹, 郑高赞, 郑建勇, 丰帆. 青年结直肠癌患者的临床病理特征及预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 449-452.
[7] 李盼, 张华秦. 不同腹腔镜胆囊切除术治疗胆囊结石的疗效比较研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 388-391.
[8] 陈育纯, 王倩倩, 彭天明, 李勇, 田凯文, 刘志烨, 吴坤林, 蒲小勇, 刘久敏. 基于GEO数据库探究前列腺癌淋巴结转移和内脏转移中基因差异及预后[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(05): 579-585.
[9] 腾鹏, 田景昌, 鄂春翔, 向阳, 田伯宇. 肌层浸润性膀胱癌患者根治性膀胱切除术预后列线图模型的构建及验证[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(05): 645-652.
[10] 张燕, 许丁伟, 胡满琴, 黄昊扬, 宋光娜, 黄洁. 术前免疫炎症指标对肝癌肝切除术患者生存预后的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(05): 707-715.
[11] 方兴保, 庞国莲, 李月宏, 蔡艳. 基于多组学分析MCAM在肝癌中表达及其与生存预后和免疫细胞浸润的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(05): 716-724.
[12] 陈佳乐, 余安海, 袁文康, 张超, 张冲. 肝切除术围手术期监测及处理[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(05): 785-788.
[13] 王军, 陈娟, 刘茜红. 血浆外泌体circLPAR1在胃癌诊断及预后评估中的临床价值[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(04): 300-304.
[14] 丁明, 郭玉军, 李晓培, 薛峰. 初始可切除性胃癌肝转移患者运用根治性及姑息性手术治疗的预后状况及其影响因素[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(04): 305-310.
[15] 何源青, 郭雷明, 冯佩, 马春宁, 岳欣. 钆塞酸二钠增强MRI多模态参数与原发性肝癌患者病情程度的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(04): 317-325.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?